ocular hallmarks in model of Alzheimer disease
What is it about?
Alzheimer's disease is a debilitating neurodegenerative disorder that relentlessly progresses over time. As the eye is an expansion of the central nervous system (CNS), checking on changes within the eye’s tissues may lead to creating an arrangement of non-invasive, differential symptomatic tests for AD that can be advance connected to other diseases. Recently, there are challenges in diagnosing AD especially ophthalmic biomarkers and eye can be a mirror to numerous neural and systemic disarranges. The only optically visible nerve tissue is the retina, so, the aim of the present work to evaluate the characteristic molecular structure changes in retina due to AD induced by AlCl3 in rats using Fourier-transform infrared spectroscopy
Why is it important?
Ocular biomarkers might improve the accuracy of Alzheimer disease diagnosis and might also serve as indirect measures of disease severity. The development of new therapies for Alzheimer disease has become of increasing societal importance given our aging population and increasing longevity, combined with the fact that this disease typically begins late in life.